RxDoctor Payments Data

James McMurray

Urology · Huntsville, ALNPI 1003913740

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $68 of the $88 with a category attached, or 77.2%. 3 manufacturers reported payments, led by Astellas Pharma US Inc at 48.9% of the total. Reporting peaked in 2019 at $56 and has fallen 64.3% since, to $20 in 2021. That places this record below the midpoint for urology clinicians in AL, where the typical reported total is $3,591.

$88in general payments, 2019–2025

Across 6 payments — averaging $14.63 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Astellas Pharma US Inc$43
  • Antares Pharma, Inc.$25
  • Pfizer$20
$4,688,391in research payments, 2019–2025

Across 342 payments — averaging $13,709 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Pfizer$4.2M
  • AbbVie$458K
  • GSK$25K
  • Urovant Sciences Inc$560

What the payments were for

  • Food & beverage$6877%
  • Gifts$2023%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Astellas Pharma US Inc3$43
Antares Pharma, Inc.2$25
Pfizer1$20

How this compares

$88 in reported general payments places this provider in the 10th percentile of 179 urology providers in Alabama.

See all urology providers in Alabama

Other urology in Huntsville

See the full list for Alabama

Where these figures come from

Is this you, or does something look wrong? →